2023年

  1. Inoue C, Ohkouchi S, Chonan T, Amata A, Hirama T, Saito-Koyama R, Kawabata Y, Suzuki T, Okada Y, Tanaka A, Kurosawa H. A case report of Indium lung with progressive emphysema and fibrosis underwent lung unilateral transplantation 20 years after the end of the exposure. Diagn Pathol. England; 2023 Jan;18(1):10. doi:10.1186/s13000-023-01303-1 PMCID: PMC9883848
  2. Numasaki M, Ito K, Takagi K, Nagashima K, Notsuda H, Ogino H, Ando R, Tomioka Y, Suzuki T, Okada Y, Nishioka Y, Unno M. Diverse and divergent functions of IL-32β and IL-32γ isoforms in the regulation of malignant pleural mesothelioma cell growth and the production of VEGF-A and  CXCL8. Cell Immunol. Netherlands; 2023 Jan;383:104652. doi:10.1016/j.cellimm.2022.104652 PMID: 36516653
  3. Eba S, Nishiyama S, Notsuda H, Oishi H, Noda M, Aoki M, Okada Y. Development of Paraneoplastic Neuromyelitis Optica after Lung Resection in a Patient with Squamous Cell Carcinoma. Ann Thorac Cardiovasc Surg. Japan; 2023 Feb;29(1):49–52. doi:10.5761/atcs.cr.21-00144 PMCID: PMC9939678
  4. Inoue M, Yamamoto H, Okada Y, Sato T, Sato Y, Suzuki K, Yoshino I, Chida M. Perioperative outcomes of minimally invasive surgery for large malignant thymic epithelial tumors and for total thymectomy. Surg Today. Japan; 2023 Mar; doi:10.1007/s00595-023-02667-z PMID: 36867230
  5. Miyabe S, Ito S, Sato I, Abe J, Tamai K, Mochizuki M, Fujimori H, Yamaguchi K, Shindo N, Shima H, Yamazaki T, Abue M, Okada Y, Yasuda J. Clinical and genomic features of non-small cell lung cancer occurring in families. Thorac Cancer. Singapore; 2023 Apr;14(10):940–952. doi:10.1111/1759-7714.14825 PMID: 36869602
  6. Kumondai M, Kikuchi M, Mizuguchi A, Hayashi N, Ui M, Hirama T, Okada Y, Sato Y, Sato T, Maekawa M, Mano N. Therapeutic Drug Monitoring of Blood Sirolimus and Tacrolimus Concentrations for Polypharmacy Management in a Lymphangioleiomyomatosis Patient Taking Two  Cytochrome P450 3A Inhibitors. Tohoku J Exp Med. Japan; 2023 May;260(1):29–34. doi:10.1620/tjem.2023.J016 PMID: 36858510
  7. Takahashi R, Takahashi T, Okada Y, Kohzuki M, Ebihara S. Factors associated with quality of life in patients receiving lung transplantation: a cross-sectional study. BMC Pulm Med. England; 2023 Jun;23(1):225. doi:10.1186/s12890-023-02526-0 PMCID: PMC10288771
  8. Watanabe T, Matsuo S, Watanabe Y, Hirama T, Matsuda Y, Noda M, Niikawa H, Oishi H, Suzuki Y, Ejima Y, Toyama H, Saiki Y, Okada Y. Bilateral lung transplant with pulmonary artery reconstruction using donor aorta for pulmonary hypertension with a giant pulmonary arterial aneurysm. Eur J Cardiothorac Surg. Germany; 2023 Jun;63(6):ezad234. doi:10.1093/ejcts/ezad234 PMID: 37335855
  9. Kumata S, Notsuda H, Su M, Saito‐Koyama R, Tanaka R, Suzuki Y, Funahashi J, Endo S, Yokota I, Takai T, Okada Y. Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer. Thoracic Cancer. 2023 Jun 8;1759-7714.14991. doi:10.1111/1759-7714.14991
  10. Ikeda M, Wakatsuki Y, Oga T, Tokuno J, Sugimoto S, Ishihara M, Okada Y, Akiba M, Kayawake H, Tanaka S, Yamada Y, Yutaka Y, Ohsumi A, Nakajima D, Hamaji M, Kimura J, Chen-Yoshikawa TF, Date H. One-year change in the health status predicts the subsequent hospitalization and mortality in patients waitlisted for lung transplantation in Japan. Respir Investig. Netherlands; 2023 Jul;61(4):478–484. doi:10.1016/j.resinv.2023.04.004 PMID: 37196571
  11. Ui M, Hirama T, Akiba M, Honda M, Kikuchi T, Okada Y. Cellular and humoral immune responses after a third dose of SARS-CoV-2 mRNA vaccine in lung transplant recipients in Japan. Vaccine. Netherlands; 2023 Jul;41(31):4534–4540. doi:10.1016/j.vaccine.2023.06.011 PMCID: PMC10250153
  12. Fukutomi T, Taniyama Y, Sato C, Okamoto H, Niikawa H, Okada Y, Kamei T. A Case of Esophageal Cancer Treated by Thoracoscopic Esophagectomy after Bilateral Cadaveric Lung Transplantation. Ann Thorac Cardiovasc Surg. Japan; 2023 Aug;29(4):200–205. doi:10.5761/atcs.cr.21-00203 PMCID: PMC10466120
  13. Oishi H, Okada Y, Suzuki Y, Hirama T, Ejima Y, Fujimaki S-I, Sugawara S, Okubo N, Horiuchi H. Impact of intraoperative use of venovenous extracorporeal membrane oxygenation on the status of von Willebrand factor large multimers during single lung  transplantation. J Thorac Dis. China; 2023 Aug;15(8):4262–4272. doi:10.21037/jtd-23-275 PMCID: PMC10482656
  14. Hayasaka K, Ohkouchi S, Saito-Koyama R, Suzuki Y, Okazaki K, Sekine H, Watanabe T, Motohashi H, Okada Y. Aging exacerbates murine lung ischemia-reperfusion injury by excessive inflammation and impaired tissue repair response. Am J Transplant. United States; 2023 Sep;S1600-6135(23)00692–5. doi:10.1016/j.ajt.2023.09.004 PMID: 37734444
  15. Hirama T, Okada Y. Roles of respirologists in lung transplantation in Japan: narrative review. J Thorac Dis. China; 2023 Sep;15(9):5174–5181. doi:10.21037/jtd-22-1716 PMCID: PMC10586989
  16. Inoue M, Yamamoto H, Okada Y, Sato T, Sato Y, Suzuki K, Yoshino I, Chida M. Perioperative outcomes of minimally invasive surgery for large malignant thymic epithelial tumors and for total thymectomy. Surg Today. Japan; 2023 Sep;53(9):1089–1099. doi:10.1007/s00595-023-02667-z PMID: 36867230
  17. Oishi H, Okada Y, Sato M, Nakajima J, Nakajima D, Shiraishi T, Sato T, Kanou T, Shintani Y, Miyoshi K, Toyooka S, Maeda S, Chida M, Matsumoto K, Nagayasu T, Suzuki H, Yoshino I, Matsuda Y, Hoshikawa Y, Date H. Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022. Surg Today. Japan; 2023 Oct;53(10):1188–1198. doi:10.1007/s00595-023-02686-w PMCID: PMC10520150
  18. Kishi M, Hayashi T, Mitani K, Tsuboshima K, Kurihara M, Hosoya M, Sekimoto Y, Okura MK, Mitsuishi Y, Okada Y, Kanno J, Yao T, Takahashi K, Seyama K. Clinicopathological Impacts of Expression of Neuronal Markers in Lymphangioleiomyomatosis. Am J Surg Pathol. United States; 2023 Nov;47(11):1252–1260. doi:10.1097/PAS.0000000000002113 PMID: 37599567
  19. Matsumura Y, Hayasaka K, Ohira T, Shiono S, Abe J, Notsuda H, Sakurada A, Suzuki H, Okada Y. Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in  lung adenocarcinoma. Interdiscip Cardiovasc Thorac Surg. England; 2023 Nov;37(5). doi:10.1093/icvts/ivad174 PMCID: PMC10640389
  20. Sato Y, Yamamoto H, Ikeda N, Konishi H, Hibi T, Endo S, Inoue M, Okada Y, Shintani Y, Toyooka S, Nakamura H, Hoshikawa Y, Chen-Yoshikawa TF, Uramoto H, Tsubochi Y, Kakizoe T, Chida M, Yoshino I. The consecutive impact of COVID-19 on thoracic surgical procedures in Japan: an analysis of data from the National Clinical Database. Surg Today. Japan; 2023 Nov; doi:10.1007/s00595-023-02763-0 PMID: 37934307
  21. Watanabe Y, Murai S, Ueda K, Watanabe T, Hirama T, Oishi H, Noda M, Okada Y. A straightforward guide to the swine left upper lobar transplant model: procedures and techniques. Multimed Man Cardiothorac Surg. 2023 Nov;2023. doi:10.1510/mmcts.2023.075 PMID: 37947495
  22. Notsuda H, Tomiyama F, Onodera K, Watanabe T, Watanabe Y, Oishi H, Niikawa H, Inoue C, Ota H, Noda M, Okada Y. Systemic-to-pulmonary artery shunt treated with transcatheter arterial embolization and subsequent lung segmentectomy. Egypt Heart J. Germany; 2023 Dec;75(1):103. doi:10.1186/s43044-023-00431-9 PMCID: PMC10733262
  23. Onodera K, Yokota I, Matsumura Y, Hayasaka K, Shiono S, Abe J, Notsuda H, Sakurada A, Suzuki H, Okada Y. Efficacy of platinum-based adjuvant chemotherapy for epidermal growth factor receptor-mutant lung adenocarcinoma. Journal of Thoracic Disease [Internet]. AME Publishing Company; 2023 Dec 30;15(12). doi:10.21037/jtd-23-1323
  24. Hayasaka K, Takeda H, Sakurada A, Matsumura Y, Abe J, Shiono S, Notsuda H, Suzuki H, Endo M, Motohashi H, Okada Y. Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation. Clin Lung Cancer. United States; 2024 Jan;25(1):e43–e51. doi:10.1016/j.cllc.2023.10.006 PMID: 37985312
  25. Noda M, Onodera K, Watanabe T, Watanabe Y, Notsuda H, Suzuki T, Oishi H, Nikawa H, Okada Y. A comparative study of surgical outcomes for secondary spontaneous pneumothorax and the postoperative survival prognostic factor: interstitial vs.  non-interstitial pneumonia. Gen Thorac Cardiovasc Surg. Japan; 2024 Jan; doi:10.1007/s11748-023-02000-y PMID: 38214883
  26. Oishi H, Hirama T, Watanabe T, Watanabe Y, Niikawa H, Noda M, Suzuki T, Notsuda H, Okada Y. Single lung transplantation using a lung graft from a donor whose contralateral lung is not suitable for lung transplantation. Gen Thorac Cardiovasc Surg. Japan; 2024 Jan; doi:10.1007/s11748-023-01999-4 PMID: 38180695